NCT01351740View on ClinicalTrials.gov

Switch to Unboosted Atazanavir With Tenofovir Study

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

January 31, 2015

Study Completion Date

December 31, 2015

Conditions
HIV Infection
Interventions
DRUG

atazanavir

switch to unboosted atazanavir 400 mg daily

DRUG

atazanavir/ritonavir

Continue current regimen of atazanavir 300 mg/ ritonavir 100 mg daily

Trial Locations (1)

V6Z1Y6

Immunodeficiency Clinic, St. Paul's Hospital, Vancouver

All Listed Sponsors
lead

University of British Columbia

OTHER

NCT01351740 - Switch to Unboosted Atazanavir With Tenofovir Study | Biotech Hunter | Biotech Hunter